KbioCo, Inc. (038530)
Market Closed
11 Aug, 06:30
KRX SM KRX SM Primary ₩
1,078. 00
+23
+2.1801%
₩
22.78B Market Cap
- P/E Ratio
23.06% Div Yield
164,216 Volume
- Eps
₩ 1,055
Previous Close Want to track 038530 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
KbioCo, Inc. (038530) Statistics
Valuation metrics
Market Cap 22.78B
Enterprise value -7.32B
Trailing P/E (ttm) -7.04
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 0.26
Price/Book (mrq) 0.24
Enterprise Value/Revenue -0.08
Enterprise Value/EBITDA 4.83
Overview
Shares outstanding 23.1M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 187.93K
Average volume (90 days) 461.93K
Price summary
52-Week low 735
52-Week high 2,750
Beta -
50-Day moving average 1,487.74
200-Day moving average 1,418.68
Dividends and splits
Forward annual dividend rate 23.06
Forward annual dividend yield 0.0234%
Trailing annual dividend rate 24.19
Trailing annual dividend yield 0.0245%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 23 Mar 2022
Ex-Dividend Date 16 Mar 2022
Last split factor 0.2:1
Last split Date 14 Apr 2026
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.14%
Operating margin -0.06%
Operational effectiveness
Return on assets -0.03%
Return on equity -0.03%
Income Statement
Revenue (ttm) 87.31B
Revenue per share (ttm) 3,820.39
Quarterly revenue growth (yoy) -0.44%
Gross profit (ttm) 12.66B
EBITDA -
Net income to common (ttm) -3.2B
Diluted EPS (ttm) -140
Quarterly earnings growth (yoy) -0.23%
Balance Sheet
Total cash (mrq) 6.02M
Total cash per share (mrq) 0.24
Total debt (mrq) 814.4M
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 5.84%
Book value per share (mrq) 4,140.44
Cash Flow
Cash flow statement -7.47B
Levered free cash flow (LFCF) -3.2B
